• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2022

    7/27/22 10:03:35 AM ET
    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Aerospace
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACHR alert in real time by email

     

    Upgrades

    • According to Edward Jones, the prior rating for NiSource Inc (NYSE:NI) was changed from Hold to Buy. For the first quarter, NiSource had an EPS of $0.75, compared to year-ago quarter EPS of $0.77. The stock has a 52-week-high of $32.59 and a 52-week-low of $26.37. At the end of the last trading period, NiSource closed at $29.20.
    • Benchmark upgraded the previous rating for Schlumberger Ltd (NYSE:SLB) from Hold to Buy. For the second quarter, Schlumberger had an EPS of $0.50, compared to year-ago quarter EPS of $0.30. The current stock performance of Schlumberger shows a 52-week-high of $49.83 and a 52-week-low of $29.98. Moreover, at the end of the last trading period, the closing price was at $35.60.
    • Raymond James upgraded the previous rating for Carvana Co (NYSE:CVNA) from Underperform to Market Perform. In the first quarter, Carvana showed an EPS of $2.89, compared to $0.46 from the year-ago quarter. The stock has a 52-week-high of $240.58 and a 52-week-low of $19.45. At the end of the last trading period, Carvana closed at $24.18.
    • Canaccord Genuity upgraded the previous rating for Newmont Corp (NYSE:NEM) from Hold to Buy. For the second quarter, Newmont had an EPS of $0.46, compared to year-ago quarter EPS of $0.83. The current stock performance of Newmont shows a 52-week-high of $86.37 and a 52-week-low of $44.00. Moreover, at the end of the last trading period, the closing price was at $46.14.
    • According to BTIG, the prior rating for International Seaways Inc (NYSE:INSW) was changed from Neutral to Buy. For the first quarter, International Seaways had an EPS of $0.28, compared to year-ago quarter EPS of $0.48. The stock has a 52-week-high of $24.99 and a 52-week-low of $13.05. At the end of the last trading period, International Seaways closed at $22.51.
    • For Celestica Inc (NYSE:CLS), Citigroup upgraded the previous rating of Sell to Neutral. In the second quarter, Celestica showed an EPS of $0.44, compared to $0.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of $13.40 and a 52-week-low of $9.12. Celestica closed at $9.94 at the end of the last trading period.

    See all analyst ratings upgrades.

     

    Downgrades

    • B of A Securities downgraded the previous rating for TransUnion (NYSE:TRU) from Buy to Neutral. In the second quarter, TransUnion showed an EPS of $0.98, compared to $0.96 from the year-ago quarter. At the moment, the stock has a 52-week-high of $119.16 and a 52-week-low of $75.03. TransUnion closed at $75.52 at the end of the last trading period.
    • Craig-Hallum downgraded the previous rating for Agilysys Inc (NASDAQ:AGYS) from Buy to Hold. Agilysys earned $0.21 in the first quarter, compared to $0.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.98 and a 52-week-low of $31.49. Agilysys closed at $51.54 at the end of the last trading period.
    • According to B of A Securities, the prior rating for PulteGroup Inc (NYSE:PHM) was changed from Buy to Neutral. For the second quarter, PulteGroup had an EPS of $2.73, compared to year-ago quarter EPS of $1.72. The current stock performance of PulteGroup shows a 52-week-high of $58.09 and a 52-week-low of $35.03. Moreover, at the end of the last trading period, the closing price was at $42.80.
    • Edward Jones downgraded the previous rating for Fortis Inc (NYSE:FTS) from Buy to Hold. Fortis earned $0.62 in the first quarter, compared to $0.61 in the year-ago quarter. The current stock performance of Fortis shows a 52-week-high of $51.66 and a 52-week-low of $44.32. Moreover, at the end of the last trading period, the closing price was at $47.36.
    • For F45 Training Holdings Inc (NYSE:FXLV), Baird downgraded the previous rating of Outperform to Neutral. For the first quarter, F45 Training Holdings had an EPS of $0.03, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $15.78 and a 52-week-low of $3.31. At the end of the last trading period, F45 Training Holdings closed at $3.51.
    • GLJ Research downgraded the previous rating for Cleveland-Cliffs Inc (NYSE:CLF) from Buy to Sell. Cleveland-Cliffs earned $1.31 in the second quarter, compared to $1.46 in the year-ago quarter. At the moment, the stock has a 52-week-high of $34.04 and a 52-week-low of $14.31. Cleveland-Cliffs closed at $16.34 at the end of the last trading period.
    • For 1Life Healthcare Inc (NASDAQ:ONEM), Stifel downgraded the previous rating of Buy to Hold. In the first quarter, 1Life Healthcare showed an EPS of $0.47, compared to $0.29 from the year-ago quarter. At the moment, the stock has a 52-week-high of $18.43 and a 52-week-low of $5.94. 1Life Healthcare closed at $16.75 at the end of the last trading period.
    • For McDonald's Corp (NYSE:MCD), Deutsche Bank downgraded the previous rating of Buy to Hold. McDonald's earned $2.55 in the second quarter, compared to $2.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $271.15 and a 52-week-low of $217.68. McDonald's closed at $257.09 at the end of the last trading period.

    See all analyst ratings downgrades.

     

    Initiations

    • With a Buy rating, Daiwa Capital initiated coverage on Lufax Holding Ltd (NYSE:LU). The price target seems to have been set at $6.40 for Lufax Holding. For the first quarter, Lufax Holding had an EPS of $0.34, compared to year-ago quarter EPS of $0.30. The current stock performance of Lufax Holding shows a 52-week-high of $7.05 and a 52-week-low of $4.08. Moreover, at the end of the last trading period, the closing price was at $4.79.
    • With a Buy rating, Lake Street initiated coverage on Dynatronics Corp (NASDAQ:DYNT). The price target seems to have been set at $4.00 for Dynatronics. For the third quarter, Dynatronics had an EPS of $0.09, compared to year-ago quarter EPS of $0.00. The stock has a 52-week-high of $1.07 and a 52-week-low of $0.43. At the end of the last trading period, Dynatronics closed at $0.65.
    • Craig-Hallum initiated coverage on DPCM Capital Inc (NYSE:XPOA) with a Buy rating. The price target for DPCM Capital is set to $13.00. The stock has a 52-week-high of $10.33 and a 52-week-low of $9.77. At the end of the last trading period, DPCM Capital closed at $9.98.
    • Ladenburg Thalmann initiated coverage on Anebulo Pharmaceuticals Inc (NASDAQ:ANEB) with a Buy rating. The price target for Anebulo Pharmaceuticals is set to $6.00. In the third quarter, Anebulo Pharmaceuticals showed an EPS of $0.08, compared to $0.69 from the year-ago quarter. The stock has a 52-week-high of $7.88 and a 52-week-low of $2.67. At the end of the last trading period, Anebulo Pharmaceuticals closed at $3.05.
    • Benchmark initiated coverage on Plexus Corp (NASDAQ:PLXS) with a Buy rating. The price target for Plexus is set to $98.00. At the moment, the stock has a 52-week-high of $99.11 and a 52-week-low of $72.88. Plexus closed at $85.81 at the end of the last trading period.
    • Mizuho initiated coverage on USA Compression Partners LP (NYSE:USAC) with a Neutral rating. The price target for USA Compression Partners is set to $18.00. In the first quarter, USA Compression Partners showed an EPS of $0.09, compared to $0.12 from the year-ago quarter. The current stock performance of USA Compression Partners shows a 52-week-high of $20.14 and a 52-week-low of $14.90. Moreover, at the end of the last trading period, the closing price was at $17.03.
    • Raymond James initiated coverage on Joby Aviation Inc (NYSE:JOBY) with a Market Perform rating. In the first quarter, Joby Aviation showed an EPS of $0.11, compared to $0.37 from the year-ago quarter. The current stock performance of Joby Aviation shows a 52-week-high of $7.60 and a 52-week-low of $3.61. Moreover, at the end of the last trading period, the closing price was at $5.17.
    • Raymond James initiated coverage on Lilium NV (NASDAQ:LILM) with a Market Perform rating. The current stock performance of Lilium shows a 52-week-high of $8.18 and a 52-week-low of $2.16. Moreover, at the end of the last trading period, the closing price was at $2.61.
    • Raymond James initiated coverage on Vertical Aerospace Ltd (NYSE:EVTL) with a Market Perform rating. The current stock performance of Vertical Aerospace shows a 52-week-high of $12.64 and a 52-week-low of $2.72. Moreover, at the end of the last trading period, the closing price was at $8.04.
    • HC Wainwright & Co. initiated coverage on Rani Therapeutics Holdings Inc (NASDAQ:RANI) with a Buy rating. The price target for Rani Therapeutics Hldgs is set to $22.00. Rani Therapeutics Hldgs earned $0.29 in the first quarter, compared to $0.00 in the year-ago quarter. The stock has a 52-week-high of $27.13 and a 52-week-low of $8.00. At the end of the last trading period, Rani Therapeutics Hldgs closed at $11.80.
    • Raymond James initiated coverage on Archer Aviation Inc (NYSE:ACHR) with an Outperform rating. The price target for Archer Aviation is set to $8.00. In the first quarter, Archer Aviation showed an EPS of $0.25, compared to $1.70 from the year-ago quarter. The stock has a 52-week-high of $6.35 and a 52-week-low of $2.61. At the end of the last trading period, Archer Aviation closed at $3.28.
    • Raymond James initiated coverage on Eve Holding Inc (NYSE:EVEX) with a Market Perform rating. At the moment, the stock has a 52-week-high of $11.84 and a 52-week-low of $5.30. Eve Holding closed at $8.19 at the end of the last trading period.
    • With an Outperform rating, Oppenheimer initiated coverage on HubSpot Inc (NYSE:HUBS). The price target seems to have been set at $350.00 for HubSpot. For the first quarter, HubSpot had an EPS of $0.54, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $659.24 and a 52-week-low of $257.21. At the end of the last trading period, HubSpot closed at $272.26.
    • With an Outperform rating, Oppenheimer initiated coverage on Veeva Systems Inc (NYSE:VEEV). The price target seems to have been set at $250.00 for Veeva Sys. Veeva Sys earned $0.99 in the first quarter, compared to $0.91 in the year-ago quarter. The stock has a 52-week-high of $257.68 and a 52-week-low of $152.04. At the end of the last trading period, Veeva Sys closed at $206.94.
    • For BigCommerce Holdings Inc (NASDAQ:BIGC), Oppenheimer initiated coverage, by setting the current rating at Perform. BigCommerce Holdings earned $0.18 in the first quarter, compared to $0.04 in the year-ago quarter. The stock has a 52-week-high of $37.75 and a 52-week-low of $12.71. At the end of the last trading period, BigCommerce Holdings closed at $14.46.
    • With an Outperform rating, Oppenheimer initiated coverage on Guidewire Software Inc (NYSE:GWRE). The price target seems to have been set at $85.00 for Guidewire Software. For the third quarter, Guidewire Software had an EPS of $0.26, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $114.00 and a 52-week-low of $69.06. Guidewire Software closed at $73.38 at the end of the last trading period.
    • Oppenheimer initiated coverage on PTC Inc (NASDAQ:PTC) with a Perform rating. The current stock performance of PTC shows a 52-week-high of $123.46 and a 52-week-low of $96.55. Moreover, at the end of the last trading period, the closing price was at $111.28.
    • Oppenheimer initiated coverage on Ansys Inc (NASDAQ:ANSS) with an Outperform rating. The price target for Ansys is set to $285.00. Ansys earned $1.36 in the first quarter, compared to $1.12 in the year-ago quarter. The stock has a 52-week-high of $403.18 and a 52-week-low of $225.92. At the end of the last trading period, Ansys closed at $253.75.
    • Oppenheimer initiated coverage on Altair Engineering Inc (NASDAQ:ALTR) with an Outperform rating. The price target for Altair Engineering is set to $60.00. In the first quarter, Altair Engineering showed an EPS of $0.38, compared to $0.31 from the year-ago quarter. The stock has a 52-week-high of $78.38 and a 52-week-low of $48.20. At the end of the last trading period, Altair Engineering closed at $53.52.
    • For Squarespace Inc (NYSE:SQSP), Oppenheimer initiated coverage, by setting the current rating at Perform. In the second quarter, Squarespace showed an EPS of $0.45, compared to $3.22 from the year-ago quarter. The current stock performance of Squarespace shows a 52-week-high of $34.97 and a 52-week-low of $14.43. Moreover, at the end of the last trading period, the closing price was at $19.50.

    See all analyst ratings initiations.

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $AGIO
    $AGYS
    $ALTR

    CompanyDatePrice TargetRatingAnalyst
    PTC Inc.
    $PTC
    2/5/2026$219.00 → $189.00Outperform
    BMO Capital Markets
    PTC Inc.
    $PTC
    2/2/2026$162.00Neutral → Underweight
    Analyst
    McDonald's Corporation
    $MCD
    2/2/2026$360.00Neutral → Buy
    BTIG Research
    Liberty Energy Inc.
    $LBRT
    2/2/2026$32.00Neutral → Overweight
    Piper Sandler
    Liberty Energy Inc.
    $LBRT
    1/30/2026$19.00 → $21.00Hold
    TD Cowen
    HubSpot Inc.
    $HUBS
    1/29/2026$465.00 → $385.00Outperform
    BMO Capital Markets
    Celestica Inc.
    $CLS
    1/28/2026$400.00Buy
    BofA Securities
    Cleveland-Cliffs Inc.
    $CLF
    1/23/2026Buy → Neutral
    Seaport Research Partners
    More analyst ratings

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets reiterated coverage on PTC with a new price target

    BMO Capital Markets reiterated coverage of PTC with a rating of Outperform and set a new price target of $189.00 from $219.00 previously

    2/5/26 7:01:51 AM ET
    $PTC
    Computer Software: Prepackaged Software
    Technology

    PTC downgraded by Analyst with a new price target

    Analyst downgraded PTC from Neutral to Underweight and set a new price target of $162.00

    2/2/26 6:50:08 AM ET
    $PTC
    Computer Software: Prepackaged Software
    Technology

    McDonald's upgraded by BTIG Research with a new price target

    BTIG Research upgraded McDonald's from Neutral to Buy and set a new price target of $360.00

    2/2/26 6:47:28 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for PYRUKYND issued to AGIOS PHARMACEUTICALS INC

    Submission status for AGIOS PHARMACEUTICALS INC's drug PYRUKYND (ORIG-1) with active ingredient MITAPIVAT has changed to 'Approval' on 02/17/2022. Application Category: NDA, Application Number: 216196, Application Classification: Type 1 - New Molecular Entity

    2/17/22 2:39:08 PM ET
    $AGIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for TIBSOVO issued to AGIOS PHARMS INC

    Submission status for AGIOS PHARMS INC's drug TIBSOVO (SUPPL-7) with active ingredient IVOSIDENIB has changed to 'Approval' on 03/18/2021. Application Category: NDA, Application Number: 211192, Application Classification: Labeling

    3/22/21 5:06:31 AM ET
    $AGIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP, Chief Accounting Officer Williams Jennifer A. was granted 2,478 shares, increasing direct ownership by 44% to 8,169 units (SEC Form 4)

    4 - TransUnion (0001552033) (Issuer)

    2/12/26 6:09:28 PM ET
    $TRU
    Finance: Consumer Services
    Finance

    President, International Skinner Todd C. was granted 16,310 shares, increasing direct ownership by 51% to 48,035 units (SEC Form 4)

    4 - TransUnion (0001552033) (Issuer)

    2/12/26 6:08:38 PM ET
    $TRU
    Finance: Consumer Services
    Finance

    EVP, Chief Legal Officer Russell Heather J was granted 15,222 shares, increasing direct ownership by 66% to 38,233 units (SEC Form 4)

    4 - TransUnion (0001552033) (Issuer)

    2/12/26 6:07:42 PM ET
    $TRU
    Finance: Consumer Services
    Finance

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Keating Melvin L bought $50,379 worth of shares (600 units at $83.96), increasing direct ownership by 2% to 35,007 units (SEC Form 4)

    4 - AGILYSYS INC (0000078749) (Issuer)

    2/3/26 3:02:52 PM ET
    $AGYS
    EDP Services
    Technology

    Director Thompson Michael N. Jr. bought $14,564 worth of shares (1,100 units at $13.24) (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    1/2/26 4:43:46 PM ET
    $JOBY
    Aerospace
    Industrials

    Director Koellner Laurette T bought $2,050,025 worth of shares (6,000 units at $341.67) (SEC Form 4)

    4 - CELESTICA INC (0001030894) (Issuer)

    10/30/25 4:37:58 PM ET
    $CLS
    Electrical Products
    Technology

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Archer To Report Fourth Quarter and Full Year 2025 Operating Update and Financial Results on March 2, 2026

    Archer Aviation Inc. (NYSE:ACHR) will report its fourth quarter and full year 2025 operating update and financial results after market close on Monday, March 2, 2026. The company will host a live webcast to discuss its results at 2:00 p.m. Pacific Time. The live webcast and replay will be available at investors.archer.com. To listen to the conference call, dial +1 646-844-6383 (domestic) or +1 833-470-1428 (international), and enter the access code 043388. Archer will also utilize Say Technologies' Q&A Platform to allow shareholders to submit and vote on questions by visiting https://app.saytechnologies.com/archer-aviation-2025-q4. About Archer Archer is designing and developing the

    2/12/26 5:30:00 PM ET
    $ACHR
    Aerospace
    Industrials

    Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Updates

    Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or "Anebulo"), today announced financial results for the three months ended December 31, 2025, and recent updates. Second Quarter Fiscal Year 2026 and Subsequent Highlights: On February 6, 2026, Anebulo announced that the Company's board of directors (the "Board") approved the voluntary delisting of the Company's common stock from The Nasdaq Capital Market ("Nasdaq") and the subsequent voluntary deregistration of its common stock with the U.S. Securities and Exchange Commission ("SEC") in order to t

    2/12/26 4:15:00 PM ET
    $ANEB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Record Defense AI Spending Opens a Procurement Window

    Issued on behalf of VisionWave Holdings, Inc. NEW YORK, Feb. 12, 2026 /PRNewswire/ -- USA News Group News Commentary – The Pentagon just carved out its first-ever standalone budget line for autonomy, requesting $13.4 billion for AI-driven platforms[1] across aerial, ground, and maritime domains. That spending lands as the U.S. Army outsources its entire helicopter pilot training pipeline[2] to a single contractor under a 26-year deal at Fort Rucker, replacing four fragmented contracts with one enterprise training up to 1,500 aviators per year. VisionWave Holdings Inc. (NASDAQ:VWAV), Lockheed Martin (NYSE:LMT), Northrop Grumman (NYSE:NOC), Archer Aviation (NYSE:ACHR), and Woodward (NASDAQ:WWD

    2/12/26 10:28:00 AM ET
    $ACHR
    $LMT
    $NOC
    Aerospace
    Industrials
    Military/Government/Technical
    Industrial Machinery/Components

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    SEC Filings

    View All

    SEC Form 10-Q filed by Anebulo Pharmaceuticals Inc.

    10-Q - Anebulo Pharmaceuticals, Inc. (0001815974) (Filer)

    2/12/26 4:30:45 PM ET
    $ANEB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3ASR filed by Agios Pharmaceuticals Inc.

    S-3ASR - AGIOS PHARMACEUTICALS, INC. (0001439222) (Filer)

    2/12/26 4:18:39 PM ET
    $AGIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Anebulo Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Anebulo Pharmaceuticals, Inc. (0001815974) (Filer)

    2/12/26 4:15:33 PM ET
    $ANEB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Leadership Updates

    Live Leadership Updates

    View All

    James D. Farley, Jr. Elected to McDonald's Board of Directors

    CHICAGO, Feb. 10, 2026 /PRNewswire/ -- McDonald's Corporation (NYSE:MCD) today announced the election of James D. Farley, Jr., to its Board of Directors, effective February 4, 2026.  Mr. Farley currently serves as President and CEO of Ford Motor Company and sits on Ford's Board of Directors, where he is guiding the company's Ford+ transformation, a strategy centered on digital innovation, customer-centric design, and operational modernization. He brings more than 30 years of experience leading complex global organizations and transforming iconic consumer brands. He previously

    2/10/26 9:15:00 AM ET
    $MCD
    Restaurants
    Consumer Discretionary

    PulteGroup Announces Appointment of Kristin Gannon to its Board of Directors

    PulteGroup, Inc. (NYSE:PHM), the nation's third largest homebuilder, today announced the appointment of Kristin Gannon, Managing Director at Eastdil Secured, as a new independent director to its Board, effective February 10, 2026. Ms. Gannon will serve on the Nominating and Governance Committee and the Audit Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260209620865/en/ "Kristin brings more than two decades of deep experience in real estate finance, strategic advisory, and capital markets, making her an exceptional addition to our Board," said Thomas J. Folliard, Chairman of the Board of PulteGroup. "Her leadership a

    2/9/26 8:00:00 AM ET
    $PHM
    Homebuilding
    Consumer Discretionary

    Vertical Aerospace Selects Evolito as Electric Propulsion Unit Partner for Valo

    Evolito to supply electric propulsion units for Valo, Vertical's commercial aircraft Companies to jointly certify the electric engines with UK CAA and EASA Evolito joins Honeywell, Syensqo and Aciturri as key suppliers, strengthening Valo's path to commercialization Vertical Aerospace ("Vertical" or "Company") (NYSE:EVTL), a global aerospace and technology company that is pioneering electric aviation, today announced a new long-term partnership with Evolito, a leader in high-performance electric propulsion systems, to supply electric propulsion units ("EPUs") - electric engines - that will power Valo, Vertical's commercial eVTOL aircraft. This press release features multimedia. V

    2/5/26 4:00:00 AM ET
    $EVTL
    Aerospace
    Industrials

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Financials

    Live finance-specific insights

    View All

    Archer To Report Fourth Quarter and Full Year 2025 Operating Update and Financial Results on March 2, 2026

    Archer Aviation Inc. (NYSE:ACHR) will report its fourth quarter and full year 2025 operating update and financial results after market close on Monday, March 2, 2026. The company will host a live webcast to discuss its results at 2:00 p.m. Pacific Time. The live webcast and replay will be available at investors.archer.com. To listen to the conference call, dial +1 646-844-6383 (domestic) or +1 833-470-1428 (international), and enter the access code 043388. Archer will also utilize Say Technologies' Q&A Platform to allow shareholders to submit and vote on questions by visiting https://app.saytechnologies.com/archer-aviation-2025-q4. About Archer Archer is designing and developing the

    2/12/26 5:30:00 PM ET
    $ACHR
    Aerospace
    Industrials

    Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

    PYRUKYND® (mitapivat) worldwide net revenues of $20.0 million in fourth quarter and $54.0 million for full yearAQVESME™ (mitapivat) for thalassemia now available in U.S. following FDA approvalCompany will have pre-sNDA meeting with FDA for mitapivat in sickle cell disease in first quarter of 2026Phase 2 tebapivat trial in sickle cell disease fully enrolled; topline results expected in second half of 2026$1.2 billion dollars in cash, cash equivalents, and marketable securities as of December 31, 2025 CAMBRIDGE, Mass., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patie

    2/12/26 6:30:00 AM ET
    $AGIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TransUnion Announces Strong Fourth Quarter and Full-Year 2025 Results

    Exceeded revenue, Adjusted EBITDA and Adjusted Diluted Earnings Per Share guidanceDelivered 13 percent revenue growth, or 12 percent organic constant currencyDrove 19 percent U.S. Financial Services and 16 percent Emerging Verticals revenue growthRepurchased approximately $150 million of shares in fourth quarter for a total of $300 million in 2025Raised quarterly dividend to $0.125 per share, an increase from $0.115, effective fourth quarter of 2025Introducing 2026 financial guidance, we expect to deliver 8 to 9 percent revenue growth CHICAGO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- TransUnion (NYSE:TRU) (the "Company") today announced financial results for the quarter and full-year ended Decem

    2/12/26 6:18:13 AM ET
    $TRU
    Finance: Consumer Services
    Finance

    $ACHR
    $AGIO
    $AGYS
    $ALTR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Lufax Holding Ltd

    SC 13D/A - Lufax Holding Ltd (0001816007) (Subject)

    12/9/24 6:12:27 AM ET
    $LU
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13D/A filed by Vertical Aerospace Ltd.

    SC 13D/A - Vertical Aerospace Ltd. (0001867102) (Subject)

    11/25/24 5:13:22 PM ET
    $EVTL
    Aerospace
    Industrials